Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013

Date: February 28, 2013
Pages: 79
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M61F073E444EN
Leaflet:

Download PDF Leaflet

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013
Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013' provides data on the Metastatic Brain Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Brain Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Brain Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Metastatic Brain Tumor
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Metastatic Brain Tumor
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Metastatic Brain Tumor Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Direct Therapeutics, Inc.
Clinical Trial Overview of Direct Therapeutics, Inc.
Burzynski Research Institute, Inc.
Clinical Trial Overview of Burzynski Research Institute, Inc.
Monteris Medical, Inc.
Clinical Trial Overview of Monteris Medical, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Comprehensive Cancer Center of Wake Forest University
Clinical Trial Overview of Comprehensive Cancer Center of Wake Forest University
Abramson Cancer Center
Clinical Trial Overview of Abramson Cancer Center
St. Mary's Hospital
Clinical Trial Overview of St. Mary's Hospital
University College London
Clinical Trial Overview of University College London
Yale University
Clinical Trial Overview of Yale University
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
The University of Chicago
Clinical Trial Overview of The University of Chicago
University of Nebraska
Clinical Trial Overview of University of Nebraska
Federation Nationale des Centres de Lutte Contre le Cancer
Clinical Trial Overview of Federation Nationale des Centres de Lutte Contre le Cancer
Wake Forest University
Clinical Trial Overview of Wake Forest University
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
University of Colorado
Clinical Trial Overview of University of Colorado
Thomas Jefferson University
Clinical Trial Overview of Thomas Jefferson University
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Emory University
Clinical Trial Overview of Emory University
University of Medicine and Dentistry New Jersey
Clinical Trial Overview of University of Medicine and Dentistry New Jersey
Duke University
Clinical Trial Overview of Duke University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Zone, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, North America, Top Countries, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, G7 Countries, 2013*
Metastatic Brain Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, E7 Countries, 2013*
Metastatic Brain Tumor Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Phase, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Terminated Clinical Trials, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Therapeutics, Inc., 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Monteris Medical, Inc., 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Comprehensive Cancer Center of Wake Forest University, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Mary's Hospital, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Federation Nationale des Centres de Lutte Contre le Cancer, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013*

LIST OF FIGURES

Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, G7 Countries (%), 2013*
Metastatic Brain Tumor Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
Metastatic Brain Tumor Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
Metastatic Brain Tumor Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
GlobalData Methodology
Metastatic Brain Tumors - Pipeline Review, Q2 2011 US$ 500.00 Apr, 2011 · 67 pages
Metastatic Brain Tumor – Pipeline Review, H2 2012 US$ 2,000.00 Oct, 2012 · 39 pages
Brain Disease Global Clinical Trials Review, Q1, 2011 US$ 1,000.00 Feb, 2011 · 31 pages
Brain Ischemia Global Clinical Trials Review, Q1, 2011 US$ 1,000.00 Mar, 2011 · 38 pages
Peritoneal Tumor Global Clinical Trials Review, H2, 2011 US$ 1,000.00 Aug, 2011 · 122 pages

Ask Your Question

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: